Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT2071220014Phase 1Completed
Phase 1, randomised, open-label trial of voclosporin in lupus nephritis (LN) (2 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Primary PK endpoints. Started Jul 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT2071220014.